Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
10.39 EUR | -4.08% |
|
-29.15% | -56.75% |
03/07 | Top Decliners | MT |
03/07 | UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating | MT |
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.12 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-56.75% | 958.24Cr | - | ||
-45.40% | 882.02Cr | B | ||
-24.06% | 658.84Cr | B | ||
-5.07% | 604.51Cr | C+ | ||
+87.00% | 498.52Cr | C | ||
-3.36% | 458.94Cr | D- | ||
+3.01% | 435.13Cr | B | ||
-28.13% | 399.98Cr | C | ||
-19.91% | 253.03Cr | C- | ||
+154.63% | 247.31Cr | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- WBA Stock
- W8A Stock
- Ratings Walgreens Boots Alliance, Inc.